Pilo Shlomo - 05 Dec 2022 Form 4 Insider Report for Raphael Pharmaceutical Inc. (RAPH)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Shlomo Pilo
Issuer symbol
RAPH
Transactions as of
05 Dec 2022
Net transactions value
$0
Form type
4
Filing time
13 Mar 2023, 16:03:00 UTC
Previous filing
19 Jan 2022
Next filing
11 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPH Warrants to Purchase Common Stock Award $0 +1,000,000 $0.000000 1,000,000 05 Dec 2022 Common Stock 1,000,000 $1.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The warrants are exercisable immediately.